Literature DB >> 25158055

IL-17A produced by both γδ T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction.

Xiaogang Peng1, Zhicheng Xiao, Jing Zhang, Yulin Li, Yanjun Dong, Jie Du.   

Abstract

IL-17A-producing T lymphocytes play a crucial role in inflammatory kidney diseases, but their role in renal fibrosis remains to be explored. Here, we demonstrated that up-regulation of IL-17A was associated with the development of obstructive kidney injury. The primary source of IL-17A production in obstructed kidneys was infiltrating γδ T lymphocytes and CD4(+) T cells. IL-17A-deficient mice were protected from myofibroblast activation and extracellular matrix deposition, leading to reduced kidney fibrosis in response to obstructive injury. Mechanistically, IL-17A deficiency suppressed the expression of the chemokine RANTES in infiltrated CD3(+) T cells and peritubular inflammation following renal obstruction. Administration of RANTES-neutralizing antibody significantly reduced the accumulation of T cells and macrophages, and of collagen deposition in obstructed kidneys. Taken together, our results indicate that IL-17A contributes significantly to the pathogenesis of renal fibrosis by regulating RANTES-mediated inflammatory cell infiltration.
Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  IL-17A; RANTES; inflammation; obstructive nephropathy; renal fibrosis

Mesh:

Substances:

Year:  2014        PMID: 25158055     DOI: 10.1002/path.4430

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  38 in total

1.  Loss of IL-27Rα Results in Enhanced Tubulointerstitial Fibrosis Associated with Elevated Th17 Responses.

Authors:  Gaia M Coppock; Lillian R Aronson; Jihwan Park; Chengxiang Qiu; Jeongho Park; Jonathan H DeLong; Enrico Radaelli; Katalin Suszták; Christopher A Hunter
Journal:  J Immunol       Date:  2020-06-10       Impact factor: 5.422

Review 2.  Interleukin-17: Friend or foe in organ fibrosis.

Authors:  Kritika Ramani; Partha S Biswas
Journal:  Cytokine       Date:  2019-02-14       Impact factor: 3.861

3.  IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion: compensatory role of natural killer cells in athymic rats.

Authors:  Purvi Mehrotra; Jason A Collett; Seth D McKinney; Jackson Stevens; Carlie M Ivancic; David P Basile
Journal:  Am J Physiol Renal Physiol       Date:  2016-11-16

Review 4.  Tissue-Resident Lymphocytes in the Kidney.

Authors:  Jan-Eric Turner; Martina Becker; Hans-Willi Mittrücker; Ulf Panzer
Journal:  J Am Soc Nephrol       Date:  2017-11-01       Impact factor: 10.121

Review 5.  T cells and autoimmune kidney disease.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; David Klatzmann; George C Tsokos
Journal:  Nat Rev Nephrol       Date:  2017-03-13       Impact factor: 28.314

Review 6.  Interleukin-17 pathways in systemic sclerosis-associated fibrosis.

Authors:  Sakir Ahmed; Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2019-05-09       Impact factor: 2.631

7.  IL-36 Signaling Facilitates Activation of the NLRP3 Inflammasome and IL-23/IL-17 Axis in Renal Inflammation and Fibrosis.

Authors:  Hsi-Hua Chi; Kuo-Feng Hua; Yu-Chuan Lin; Ching-Liang Chu; Chih-Yu Hsieh; Yu-Juei Hsu; Shuk-Man Ka; Yu-Ling Tsai; Feng-Cheng Liu; Ann Chen
Journal:  J Am Soc Nephrol       Date:  2017-02-08       Impact factor: 10.121

Review 8.  Unconventional T cells and kidney disease.

Authors:  Hannah Kaminski; Lionel Couzi; Matthias Eberl
Journal:  Nat Rev Nephrol       Date:  2021-08-26       Impact factor: 28.314

Review 9.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

Review 10.  Shared and distinct mechanisms of fibrosis.

Authors:  Jörg H W Distler; Andrea-Hermina Györfi; Meera Ramanujam; Michael L Whitfield; Melanie Königshoff; Robert Lafyatis
Journal:  Nat Rev Rheumatol       Date:  2019-11-11       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.